This report on the Japanese Nanomedicine Market examines the global nanomedicine market with a focus on market drivers and market trends. Detailed information is provided on the Japanese market, government initiatives, R&D, key players and opportunities, providing valuable information for those interested in the Japanese nanomedicine sector.
Maths Lundin is a business consulting expert with over 30 years' experience of working in Japan. Click here to access his profile.
What are the legal aspects to consider when selecting the best entry strategy for the Japanese nanomedicine/pharmaceutical market? The Japanese pharmaceutical market is seeing more and more foreign
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.